Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac
about
Therapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.Effect of Cocoa and Its Flavonoids on Biomarkers of Inflammation: Studies of Cell Culture, Animals and HumansAbsence of nuclear factor kappaB inhibition by NSAIDs in hepatocytesInhibition of rat colon tumors by sulindac and sulindac sulfone is independent of K-ras (codon 12) mutationDeficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ miceControl of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell linesNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.APC and intestinal carcinogenesis. Insights from animal models.The role of COX-2 in intestinal cancer.Altered dynamics of intestinal cell maturation in Apc1638N/+ mice.Maternal B vitamin supplementation from preconception through weaning suppresses intestinal tumorigenesis in Apc1638N mouse offspring.Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy.The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitisThe armadillo repeat domain of Apc suppresses intestinal tumorigenesis.Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAsNon-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.Non-steroidal anti-inflammatory drugs in prevention of gastric cancer.COX-2 inhibition: a possible role in the management of prostate cancer?Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.Novel mechanism for obesity-induced colon cancer progressionNonsteroidal anti-inflammatory drug sulindac sulfide suppresses structural protein Nesprin-2 expression in colorectal cancer cellsEarly Epithelial Restitution by Nonsteroidal Anti-Inflammatory Drug-Activated Gene 1 Counteracts Intestinal Ulcerative Injuries.Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs.NSAIDs and Cell Proliferation in Colorectal Cancer.The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid.Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients.Connexin43 Expression Increases in the Epithelium and Stroma along the Colonic Neoplastic Progression Pathway: Implications for Its Oncogenic Role.Preventive Effects of Cocoa and Cocoa Antioxidants in Colon CancerInduction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens.Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.COX-2 is expressed in human pulmonary, colonic, and mammary tumors.Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon.Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus.
P2860
Q24799697-CEEEAA05-5DA4-402C-AE7C-124C282C955BQ26748878-A7F7A082-5E69-4CE3-80CD-66E148F50F8BQ28192297-94F42536-BF96-4E45-AE7E-9A3803AF7854Q28369883-07455759-F2F8-4052-96E4-7F835354E57BQ28505216-F495DBA8-46A5-4F81-83F6-6668B930F7B8Q33516239-2EEE10CF-A1AC-47C7-8DC3-F99714328B53Q33664095-3BBE5F0E-3895-4D03-87E6-ACA7996C950AQ33815903-1F1702DB-1F3B-43C9-A8D7-15158264F147Q33834286-FAFA5663-C63D-474C-80CA-DE09CF625432Q33834299-8ABA1220-2A20-4AB0-9C54-7460B854F6D7Q34003661-01EB9813-C976-4637-9459-8562ED03193DQ34027251-7C28EA56-C96E-4102-B3A7-862273DC3658Q34119511-3E6E8481-BF4D-407A-B7A0-5BEFE4B43655Q34392824-D173DE26-8050-4CDA-AF7B-98B97AB8B304Q34514072-CFD690F3-E33A-4895-BCAA-B0F0B39AF497Q35571956-8CE98695-CEC6-4F72-BC6A-6FA6B7A745FDQ36024500-F855D0EF-E449-4C89-980D-13D865555196Q36402212-82515FC5-15EF-4BDC-8D98-B72CD4510F7EQ36485784-F40CAB4F-003A-4F4A-BED1-E66421F8FA16Q36740041-ED2E1A36-CB2B-40EC-BF1F-C77910A3FBD8Q36899713-148EE5BE-6F2E-4397-BEB7-6B403B08CB6AQ37148040-CFE2192C-FD43-43F1-A43E-A293D32A4932Q37384568-88724238-5CCA-4355-83C3-B1A87EE800F9Q38412532-EB23D7B4-8652-4EB3-BCCE-F660513D1BCAQ38554955-FBE718BE-BDF9-4348-94FC-B6E077A1D835Q38974369-5E2E85E5-35D7-48A7-8512-12CEF0CB4E9AQ40280092-EBF1C6CF-3B4E-49D7-8257-990F96B7AAA1Q40528401-C57C2F6D-D1F5-427B-B2AC-BDE77F655D77Q40559845-860BFF51-1C39-4B08-91DA-0CF1196F4AD4Q41696833-76437274-A4CC-4861-A599-389CB090AA8EQ41869534-65BB5094-8680-47E1-B3E9-AFE87A559A9BQ41954627-20120D1C-99E6-4D2A-B0A4-7D1659C17093Q43942746-52F27FBE-16E9-45A7-89D0-6FC60C52D39EQ48364155-D4F9FFF8-CED5-4E5B-98EE-6C4D20EF7570Q49517664-B3EF190A-7BCF-44D1-BDF1-1C8813386CC0Q53402915-A163BE7A-E877-4255-ACE5-23BC7852C0ABQ53406369-00A16951-AA83-45F8-A752-275A278954EFQ55439392-6317E99E-5657-4060-8EB7-C27CF81E6860
P2860
Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac
description
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Januar 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/01/15)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/01/15)
@nl
наукова стаття, опублікована в січні 1999
@uk
مقالة علمية (نشرت في 15-1-1999)
@ar
name
Genotype-phenotype correlation ...... ation and response to sulindac
@ast
Genotype-phenotype correlation ...... ation and response to sulindac
@en
Genotype-phenotype correlation ...... ation and response to sulindac
@nl
type
label
Genotype-phenotype correlation ...... ation and response to sulindac
@ast
Genotype-phenotype correlation ...... ation and response to sulindac
@en
Genotype-phenotype correlation ...... ation and response to sulindac
@nl
prefLabel
Genotype-phenotype correlation ...... ation and response to sulindac
@ast
Genotype-phenotype correlation ...... ation and response to sulindac
@en
Genotype-phenotype correlation ...... ation and response to sulindac
@nl
P2093
P3181
P356
P1433
P1476
Genotype-phenotype correlation ...... ation and response to sulindac
@en
P2093
M. M. Bertagnolli
M. R. Churchill
N. N. Mahmoud
R. Kucherlapati
R. T. Bilinski
W. Edelmann
P304
P3181
P356
10.1093/CARCIN/19.1.87
P407
P577
1999-01-15T00:00:00Z